From the Journals

Study: Natpara slightly boosts health-related QoL in hypoparathyroidism

Publish date: February 23, 2018

 

FROM THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

SOURCE: Vokes, TJ et al. J Clin Endocrinol Metab. 2018 Feb 1;103(2):722-31

Pages

Recommended Reading

Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
MDedge Internal Medicine
In hypoparathyroidism, phosphate, calcium levels may matter
MDedge Internal Medicine
Add-on mycophenolate boosts efficacy of steroids for Graves’ orbitopathy
MDedge Internal Medicine
Long-term methimazole therapy improves Graves disease remission rate
MDedge Internal Medicine
Patients prefer higher dose of levothyroxine despite lack of objective benefit
MDedge Internal Medicine
Autoimmune endocrinopathies spike after celiac disease diagnosis
MDedge Internal Medicine
Generic, brand-name levothyroxine have similar cardiovascular outcomes
MDedge Internal Medicine
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Internal Medicine
Iodine deficiency linked to delay in pregnancy
MDedge Internal Medicine
PCOS may influence the diversity of the gut microbiome
MDedge Internal Medicine